Dermatology Handbook
For UK audiences

The professionals guide to product selection

Search

Results

Fucibet Lipid Cream
LEO Pharma

Fucibet Lipid Cream

Fucibet Lipid Cream combines the well-known anti-inflammatory and antipruritic effects of betamethasone with the topical antibacterial action of fusidic acid. Betamethasone valerate is a topical steroid that is rapidly effective in inflammatory dermatoses that normally respond to this form of therapy. More refractory conditions can often be treated successfully. When applied topically, fusidic acid is effective against Staphylococcus aureus, Streptococcus, Corynebacterium, Neisseria and certain clostridia and Bacteroides. Concentrations of 0.03-0.12µ per ml inhibit nearly all strains of S. aureus. The antibacterial activity of fusidic acid is not diminished in the presence of betamethasone
Fucibet Cream
LEO Pharma

Fucibet Cream

Fucibet Cream combines the well-known anti-inflammatory and antipruritic effects of betamethasone with the topical antibacterial action of fusidic acid. Betamethasone valerate is a topical steroid that is rapidly effective in inflammatory dermatoses that normally respond to this form of therapy. More refractory conditions can often be treated successfully. When applied topically, fusidic acid is effective against Staphylococcus aureus, Streptococcus, Corynebacterium, Neisseria and certain clostridia and Bacteroides. Concentrations of 0.03-0.12µg per ml inhibit nearly all strains of S. aureus. The antibacterial activity of fusidic acid is not diminished in the presence of betamethasone
Fucidin H Cream
LEO Pharma

Fucidin H Cream

Fucidin H Cream combines the potent topical antibacterial action of fusidic acid with the anti-inflammatory and antipruritic effects of hydrocortisone. Concentrations of 0.03–0.12µg/ml of fusidic acid inhibit nearly all strains of Staphylococcus aureus. Topical application of fusidic acid is also effective against Streptococcus, Corynebacterium, Neisseria and certain clostridia
Protopic
LEO Pharma

Protopic

The mechanism of action of tacrolimus in atopic dermatitis is not fully understood. Whilethe following have been observed, the clinical significance of these observations in atopicdermatitis is not known. Via its binding to a specific cytoplasmic immunophilin (FKBP12),tacrolimus inhibits calcium-dependent signal transduction pathways in T cells, therebypreventing the transcription and synthesis of IL-2, IL-3, IL-4, IL-5 and other cytokines such asGM-CSF, TNF-α and IFN-γ. In patients with atopic dermatitis, improvement of skin lesionsduring treatment with tacrolimus ointment was associated with reduced Fc receptorexpression on Langerhans cells and a reduction of their hyperstimulatory activity towards Tcells. Tacrolimus ointment does not affect collagen synthesis in humans.
Finacea
LEO Pharma

Finacea

Finacea contains azelaic acid, an antimicrobial that has a direct effect on follicular hyperkeratosis as a therapy for acne
Skinoren
LEO Pharma

Skinoren

Contains azelaic acid, which inhibits the growth of the Propionibacteria involved in the development of acne and the production of acne-promoting fatty acids. Azelaic acid also reduces the multiplication and keratinisation of keratinocytes, and therefore restricts the formation of comedones.
Trimovate Cream
Ennogen

Trimovate Cream

A water-miscible cream containing clobetasone 17-butyrate 0.05% w/w, oxytetracycline 3.0% w/w as calcium oxytetracycline and nystatin 100,000 units per gram.
Derma Protective Plus
Ennogen

Derma Protective Plus

Fragrance-free, non-greasy, viscous skin protectant containing dimethicone. Protects against moisture-associated skin damage related to incontinence.
Thirty-30
Ennogen

Thirty-30

An emollient containing 30% emulsifying wax and 30% yellow soft paraffin
Soffen Cream
Ennogen

Soffen Cream

White soft paraffin 13.2% and liquid paraffin light 10.5% cream